Overwhelming Post-Splenectomy Infection and a Lapsed Prophylaxis
A rapid-onset sepsis in a patient whose post-splenectomy prophylaxis quietly lapsed years ago raises both an urgent empiric-antibiotic question and a genuinely unsettled one about how long that prophylaxis should have continued.
Daniel W. is 44 and coaches his son's Little League team most spring evenings, the kind of ordinary commitment that made this morning's sudden fever feel, at first, like something he could shake off before practice. Within six hours of the fever starting he was rigoring and confused enough that his wife called 911 rather than waiting to see a doctor in the morning, and he arrived in the emergency department hypotensive and difficult to arouse. He had a splenectomy twelve years ago after a motorcycle accident and, by his wife's account, stopped his penicillin prophylaxis around three years out — nobody had specifically told him to continue it indefinitely, he'd felt entirely well in the years since, and it had simply stopped being part of his routine. He is otherwise healthy, with no other chronic medical conditions.
What he has, presenting this way this fast in an asplenic patient, has to be treated as overwhelming post-splenectomy infection until proven otherwise — a syndrome that can progress from first symptom to purpura fulminans and death within twenty-four hours, driven overwhelmingly by encapsulated organisms the spleen would normally clear efficiently through its role in opsonized-particle filtration and early antibody response, chiefly Streptococcus pneumoniae, but also Haemophilus influenzae and Neisseria meningitidis — the three organisms the British Committee for Standards in Haematology's asplenia guidance builds its entire vaccination and prophylaxis schedule around. The spleen's filtering function is not easily substituted elsewhere in the body, which is exactly why an asplenic patient's risk of fulminant pneumococcal sepsis remains elevated for the rest of his life, not just in some early post-operative window — a fact his own twelve symptom-free years since surgery had, in practice, let him and everyone around him forget.
The empiric antibiotic choice has to assume the worst-case pathogen profile rather than the average one: penicillin- and even cephalosporin-non-susceptible pneumococcal strains are common enough now that a third-generation cephalosporin alone is not automatically considered adequate empiric monotherapy in a patient this sick, which is what is actually driving the antibiotic conversation at his bedside in the first hour.
The first hour after a spleen that's been gone twelve years finally mattered again
Ceftriaxone and vancomycin, now, with aggressive fluid resuscitation and vasopressor support standing by — this is overwhelming post-splenectomy infection until something proves otherwise, and the mortality curve on this diagnosis is measured in hours, not days. I'm not waiting on cultures to decide whether he needs double coverage; a patient this sick, this fast, after this history, gets the broadest reasonable empiric regimen from the first dose.
Agreed completely on the acute regimen — ceftriaxone alone isn't safe empiric monotherapy anymore given how common penicillin- and cephalosporin-non-susceptible pneumococcus has become, and vancomycin covers that gap along with anything resistant we haven't identified yet.
Once he's stabilized, though, there's a second question this case is really raising: he was on prophylaxis and stopped it at three years, which isn't a documentation failure so much as a genuine gap in how long adult post-splenectomy prophylaxis is actually supposed to run. The evidence base for indefinite prophylaxis is much stronger in children and in sickle cell disease specifically than it is for an adult more than a couple of years out from a trauma splenectomy — the British Committee for Standards in Haematology's asplenia guidance — Davies and colleagues — is explicit that the evidence is strongest for the first one to two years, and that lifelong prophylaxis is firmly recommended for defined high-risk groups rather than for every splenectomized adult, with duration otherwise an individualized decision.
I'd push back a little on treating that as settled enough to let him stop again. The evidence gap you're describing is real, but it cuts toward better patient education and lifelong access to prophylaxis he can restart quickly if he chooses, not toward confidently telling the next post-splenectomy patient prophylaxis is optional past year two.
What actually failed here wasn't the evidence base, it was the system — nobody re-anchored him to a plan once the initial post-operative instructions faded, and he didn't have current pneumococcal or meningococcal vaccination status on record either. Whatever we decide about prophylaxis duration, the vaccination gap isn't ambiguous at all, and closing it before discharge is the one part of this conversation that isn't actually a judgment call.
Agreed and started within the first hour: ceftriaxone plus vancomycin empirically, with fluids and vasopressor support for his hypotension, ICU admission, and a working diagnosis of overwhelming post-splenectomy infection pending cultures.
Left genuinely unresolved, for his discharge planning rather than tonight: whether he restarts indefinite penicillin prophylaxis once he recovers, or is instead counseled on infection early-warning signs with a prophylaxis-on-hand plan for future high-risk situations, given the real disagreement about how strong the evidence for indefinite adult prophylaxis actually is. What all three agreed on without any disagreement: catch-up pneumococcal, meningococcal, and Hib vaccination before he leaves the hospital, and a written, durable asplenia care plan he keeps, rather than one that quietly stops being followed the way the antibiotic did.